Related references
Note: Only part of the references are listed.Inflammation as a therapeutic target in myocardial infarction: learning from past failures to meet future challenges
Amit Saxena et al.
TRANSLATIONAL RESEARCH (2016)
Toll-like receptor-4 is upregulated in plaque debris of patients with acute coronary syndrome more than Toll-like receptor-2
Shinji Satoh et al.
HEART AND VESSELS (2016)
IL-29 Enhances LPS/TLR4-Mediated Inflammation in Rheumatoid Arthritis
Donghua Xu et al.
CELLULAR PHYSIOLOGY AND BIOCHEMISTRY (2015)
Inflammation, Immunity, and Hypertensive End-Organ Damage
William G. McMaster et al.
CIRCULATION RESEARCH (2015)
Inflammation in cardiac injury, repair and regeneration
Nikolaos G. Frangogiannis
CURRENT OPINION IN CARDIOLOGY (2015)
Up-regulated TLR4 in cardiomyocytes exacerbates heart failure after long-term myocardial infarction
Li Liu et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2015)
Viral myocarditis-diagnosis, treatment options, and current controversies
Ari Pollack et al.
NATURE REVIEWS CARDIOLOGY (2015)
Astragaloside IV Attenuates Injury Caused by Myocardial Ischemia/Reperfusion in Rats via Regulation of Toll-Like Receptor 4/Nuclear Factor-κB Signaling Pathway
Meili Lu et al.
PHYTOTHERAPY RESEARCH (2015)
Necrotic Myocardial Cells Release Damage-Associated Molecular Patterns That Provoke Fibroblast Activation In Vitro and Trigger Myocardial Inflammation and Fibrosis In Vivo
Weili Zhang et al.
JOURNAL OF THE AMERICAN HEART ASSOCIATION (2015)
Toll-like receptor 4 Asp299Gly and Thr399Ile polymorphisms: New data and a meta-analysis
Nezha Senhaji et al.
BMC GASTROENTEROLOGY (2014)
Regulation and actions of activin A and follistatin in myocardial ischaemia-reperfusion injury
Yi Chen et al.
CYTOKINE (2014)
S100A1 is released from ischemic cardiomyocytes and signals myocardial damage via Toll-like receptor 4
David Rohde et al.
EMBO MOLECULAR MEDICINE (2014)
Chronic treatment with metformin suppresses toll-like receptor 4 signaling and attenuates left ventricular dysfunction following myocardial infarction
Hamid Soraya et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2014)
RP105 deficiency aggravates cardiac dysfunction after myocardial infarction in mice
M. C. Louwe et al.
INTERNATIONAL JOURNAL OF CARDIOLOGY (2014)
CD36-Mediated Hematoma Absorption following Intracerebral Hemorrhage: Negative Regulation by TLR4 Signaling
Huang Fang et al.
JOURNAL OF IMMUNOLOGY (2014)
Systemic toll-like receptor and interleukin-18 pathway activation in patients with acute ST elevation myocardial infarction
Tineke C. T. M. van der Pouw Kraan et al.
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY (2014)
Aortic valve calcification is mediated by a differential response of aortic valve interstitial cells to inflammation
Neil Venardos et al.
JOURNAL OF SURGICAL RESEARCH (2014)
Functional assessment of the mutational effects of human IRAK4 and MyD88 genes
Takahiro Yamamoto et al.
MOLECULAR IMMUNOLOGY (2014)
Therapeutic Administration of the Chemokine CXCL1/KC Abrogates Autoimmune Inflammatory Heart Disease
Kurt Bachmaier et al.
PLOS ONE (2014)
High mechanical strain of primary intervertebral disc cells promotes secretion of inflammatory factors associated with disc degeneration and pain
Rahul Gawri et al.
ARTHRITIS RESEARCH & THERAPY (2014)
Tenascin-C Aggravates Autoimmune Myocarditis via Dendritic Cell Activation and Th17 Cell Differentiation
Tomoko Machino-Ohtsuka et al.
JOURNAL OF THE AMERICAN HEART ASSOCIATION (2014)
Innate immune receptors in heart failure: Side effect or potential therapeutic target?
Katharina B. Wagner et al.
WORLD JOURNAL OF CARDIOLOGY (2014)
Assembly and localization of Toll-like receptor signalling complexes
Nicholas J. Gay et al.
NATURE REVIEWS IMMUNOLOGY (2014)
Notch1 Promotes the Pro-Osteogenic Response of Human Aortic Valve Interstitial Cells via Modulation of ERK1/2 and Nuclear Factor-κB Activation
Qingchun Zeng et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2013)
Adiponectin protects against Toll-like receptor 4-mediated cardiac inflammation and injury
Alexander Jenke et al.
CARDIOVASCULAR RESEARCH (2013)
The HMGB1-TLR4 axis contributes to myocardial ischemia/reperfusion injury via regulation of cardiomyocyte apoptosis
Hua-Sheng Ding et al.
GENE (2013)
Effect of Eritoran, an Antagonist of MD2-TLR4, on Mortality in Patients With Severe Sepsis The ACCESS Randomized Trial
Steven M. Opal et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2013)
S100A8 and S100A9: DAMPs at the Crossroads between Innate Immunity, Traditional Risk Factors, and Cardiovascular Disease
Alexandru Schiopu et al.
MEDIATORS OF INFLAMMATION (2013)
The innate immune response in reperfused myocardium
Leo Timmers et al.
CARDIOVASCULAR RESEARCH (2012)
Innate Immune Function by Toll-like Receptors: Distinct Responses in Newborns and the Elderly
Tobias R. Kollmann et al.
IMMUNITY (2012)
Pharmacology and therapeutic potential of pattern recognition receptors
M. J. Paul-Clark et al.
PHARMACOLOGY & THERAPEUTICS (2012)
Structural Biology of the Toll-Like Receptor Family
Jin Young Kang et al.
ANNUAL REVIEW OF BIOCHEMISTRY, VOL 80 (2011)
Toll-Like Receptors: New Players in Myocardial Ischemia/Reperfusion Injury
Tuanzhu Ha et al.
ANTIOXIDANTS & REDOX SIGNALING (2011)
The Emerging Role of Innate Immunity in the Heart and Vascular System For Whom the Cell Tolls
Douglas L. Mann
CIRCULATION RESEARCH (2011)
Role of Toll-like receptors in cardiovascular diseases
Jesus G. Vallejo
CLINICAL SCIENCE (2011)
The toll-like receptor 4-antagonist eritoran reduces murine cardiac hypertrophy
Heidi Ehrentraut et al.
EUROPEAN JOURNAL OF HEART FAILURE (2011)
Toll-like receptor modulators: a patent review (2006-2010)
Shaherin Basith et al.
EXPERT OPINION ON THERAPEUTIC PATENTS (2011)
TRIF Is a Critical Survival Factor in Viral Cardiomyopathy
Alexander Riad et al.
JOURNAL OF IMMUNOLOGY (2011)
Adenosine Reduces Cell Surface Expression of Toll-Like Receptor 4 and Inflammation in Response to Lipopolysaccharide and Matrix Products
Benjamin Haas et al.
JOURNAL OF CARDIOVASCULAR TRANSLATIONAL RESEARCH (2011)
The interleukin-1 receptor-associated kinases: Critical regulators of innate immune signalling
Sinead Flannery et al.
BIOCHEMICAL PHARMACOLOGY (2010)
Pattern Recognition Receptors and Inflammation
Osamu Takeuchi et al.
CELL (2010)
Phase 2 trial of eritoran tetrasodium (E5564), a Toll-like receptor 4 antagonist, in patients with severe sepsis
Mark Tidswell et al.
CRITICAL CARE MEDICINE (2010)
A Molecular Mechanism for Toll-IL-1 Receptor Domain-containing Adaptor Molecule-1-mediated IRF-3 Activation
Megumi Tatematsu et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
Helical assembly in the MyD88-IRAK4-IRAK2 complex in TLR/IL-1R signalling
Su-Chang Lin et al.
NATURE (2010)
TLR4/MyD88/PI3K interactions regulate TLR4 signaling
Michelle H. W. Laird et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2009)
Role of pattern-recognition receptors in cardiovascular health and disease
J. A. Mitchell et al.
BIOCHEMICAL SOCIETY TRANSACTIONS (2007)
Protection against myocardial ischemia/reperfusion injury in TLR4-deficient mice is mediated through a phosphoinositide 3-kinase-dependent mechanism
Fang Hua et al.
JOURNAL OF IMMUNOLOGY (2007)
The family of five: TIR-domain-containing adaptors in Toll-like receptor signalling
Luke A. J. O'Neill et al.
NATURE REVIEWS IMMUNOLOGY (2007)
Therapeutic targeting of innate immunity with Toll-like receptor agonists and antagonists
Holger Kanzler et al.
NATURE MEDICINE (2007)
DAMPs, PAMPs and alarmins: all we need to know about danger
Marco E. Bianchi
JOURNAL OF LEUKOCYTE BIOLOGY (2007)
Combinatorial pattern recognition receptor signaling alters the balance of life and death in macrophages
Tracie A. Seimon et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
The interplay hetween pro-death and pro-survival signaling pathways in myocardial ischemia/reperfusion injury: Apoptosis meets autophagy
Anne Hamacher-Brady et al.
CARDIOVASCULAR DRUGS AND THERAPY (2006)
Toll-like receptor 4 gene polymorphisms and myocardial infarction:: no association in a Caucasian population
Werner Koch et al.
EUROPEAN HEART JOURNAL (2006)
Inhibition of toll-like receptor 4 with eritoran attenuates myocardial ischemia-reperfusion injury
Akira Shimamoto et al.
CIRCULATION (2006)
Modulation of the phosphoinositide 3-kinase signaling pathway alters host response to sepsis, inflammation, and ischemia/reperfusion injury
DL Williams et al.
SHOCK (2006)
How Toll-like receptors signal: what we know and what we don't know
LAJ O'Neill
CURRENT OPINION IN IMMUNOLOGY (2006)
Jak/STAT/SOCS signaling circuits and associated cytokine-mediated inflammation and hypertrophy in the heart
Andrew M. Terrell et al.
SHOCK (2006)
Reduced cardiac hypertrophy in toll-like receptor 4-deficient mice following pressure overload
TZ Ha et al.
CARDIOVASCULAR RESEARCH (2005)
Myeloid differentiation factor-88 plays a crucial role in the pathogenesis of coxsackievirus B3-induced myocarditis and influences type I interferon production
K Fuse et al.
CIRCULATION (2005)
Negative regulation of Toll-like receptor-mediated immune responses
FY Liew et al.
NATURE REVIEWS IMMUNOLOGY (2005)
CD14 is required for MyD88-independent LPS signaling
ZF Jiang et al.
NATURE IMMUNOLOGY (2005)
Tissue-specific mRNA expression profiles of human toll-like receptors and related genes
M Nishimura et al.
BIOLOGICAL & PHARMACEUTICAL BULLETIN (2005)
Toll-like receptors in innate immunity
K Takeda et al.
INTERNATIONAL IMMUNOLOGY (2005)
Modulating Toll-like receptor mediated signaling by (1→3)-β-D-glucan rapidly induces cardioprotection
CF Li et al.
CARDIOVASCULAR RESEARCH (2004)
Association of hypo-responsive toll-like receptor 4 variants with risk of myocardial infarction
K Edfeldt et al.
EUROPEAN HEART JOURNAL (2004)
RIP1 is an essential mediator of Toll-like receptor 3-induced NF-κB activation
E Meylan et al.
NATURE IMMUNOLOGY (2004)
Association of the toll-like receptor 4 gene Asp299Gly polymorphism with acute coronary events
N Ameziane et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2003)
Toll/IL-1 receptor domain-containing adaptor inducing IFN-β (TRIF) associates with TNF receptor-associated factor 6 and TANK-Binding kinase 1, and activates two distinct transcription factors, NF-κB and IFN-regulatory factor-3, in the toll-like receptor signaling
S Sato et al.
JOURNAL OF IMMUNOLOGY (2003)
IL-12 receptor β1 and Toll-like receptor 4 increase IL-1β- and IL-18-associated myocarditis and Coxsackievirus replication
D Fairweather et al.
JOURNAL OF IMMUNOLOGY (2003)
Cutting edge: Role of Toll-like receptor 1 in mediating immune response to microbial lipoproteins
O Takeuchi et al.
JOURNAL OF IMMUNOLOGY (2002)
Essential role of MD-2 in LPS responsiveness and TLR4 distribution
Y Nagai et al.
NATURE IMMUNOLOGY (2002)
Discrimination of bacterial lipoproteins by Toll-like receptor 6
O Takeuchi et al.
INTERNATIONAL IMMUNOLOGY (2001)